| Bioactivity | (Rac)-2-Aminothiazoline-4-carboxylic acid-13C,15N2is the deuterium labeled2-Amino-4,5-dihydrothiazole-4-carboxylic acid(HY-W051624)[1]. |
| Invitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。 |
| Name | (Rac)-2-Aminothiazoline-4-carboxylic acid-13C,15N2 |
| CAS | 1346599-59-4 |
| Formula | C313CH615N2O2S |
| Molar Mass | 149.15 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. |
(Rac)-2-Aminothiazoline-4-carboxylic acid-13C,15N2
CAS: 1346599-59-4 F: C313CH615N2O2S W: 149.15
(Rac)-2-Aminothiazoline-4-carboxylic acid-13C,15N2is the deuterium labeled2-Amino-4,5-dihydrothiazole-4-carboxylic acid(
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.